Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients

Journal of Investigative Dermatology

Volumn 134, Issue 1, 2014, Pages 141-149

  Sturm, Richard A ^a   Fox, Carly ^a   McClenahan, Phil ^a   Jagirdar, Kasturee ^a   Ibarrola Villava, Maider ^a,b   Banan, Parastoo ^a,c   Abbott, Nicola C ^a,c   Ribas, Gloria ^b   Gabrielli, Brian ^a   Duffy, David L ^d   Soyer, H Peter ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR;

ADULT; AGED; ALLELE; AMELANOTIC MELANOMA; ARTICLE; AUSTRALIA; BENIGN NEVI; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYCLIN DEPENDENT KINASE INHIBITOR 2A GENE; DYSPLASTIC NEVUS; EYE COLOR; FEMALE; FIRST DEGREE RELATIVE; GENE INTERACTION; GENOTYPE; HAIR COLOR; HETEROZYGOTE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR E318K ALLELE; MIDDLE AGED; NEVUS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN COLOR; SOMATIC MUTATION; SUMOYLATION; WILD TYPE;

EID: 84890994849     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.272     Document Type: Article

References (42)

1. Baxter AJ, Hughes MC, Kvaskoff M et al. (2008) The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures. Twin Res Hum 11: 183-96
2. Beaumont KA, Wong SS, Ainger SA et al. (2011) Melanocortin MC(1) receptor in human genetics and model systems. Eur J Pharmacol 660: 103-10
3. Bertolotto C, Lesueur F, Giuliano S et al. (2011) A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480: 94-8
4. Beuret L, Ohanna M, Strub T et al. (2011) BRCA1 is a new MITF target gene. Pigment Cell Melanoma Res 24: 725-7
5. Box NF, Duffy DL, Chen W et al. (2001) MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 69: 765-73
6. Cheli Y, Giuliano S, Botton T et al. (2011) Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene 30: 2307-18
7. Cheli Y, Giuliano S, Fenouille N et al. (2012) Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 31: 2461-70
8. Cheli Y, Ohanna M, Ballotti R et al. (2010) Fifteen-year quest for microphthalmia- associated transcription factor target genes. Pigment Cell Melanoma Res 23: 27-40
9. Cook AL, Chen W, Thurber AE et al. (2009) Analysis of cultured human melanocytes based on polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P loci. J Invest Dermatol 129: 392-405
10. Cronin JC, Wunderlich J, Loftus SK et al. (2009) Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res 22: 435-44
11. Cuellar F, Puig S, Kolm I et al. (2009) Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers. Br J Dermatol 160: 48-53
12. Curchin C, Wurm E, Jagirdar K et al. (2012) Dermoscopy, reflectance confocal microscopy and histopathology of an amelanotic melanoma from an individual heterozygous for MC1R and tyrosinase variant alleles. Australas J Dermatol 53: 291-4
13. Douglas NC, Borgovan T, Carroll MJ et al. (2011) Dermoscopic naevus patterns in people at high versus moderate/low melanoma risk in Queensland. Australas J Dermatol 52: 248-53
14. Du J, Widlund HR, Horstmann MA et al. (2004) Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 6: 565-76
15. Duffy DL, Box NF, ChenWet al. (2004) Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 13: 447-61
16. Duffy DL, Iles MM, Glass D et al. (2010a) IRF4 variants have age-specific effects on nevus count and predispose to melanoma. Am J Hum Genet 87: 6-16
17. Duffy DL, Zhao ZZ, Sturm RA et al. (2010b) Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J Invest Dermatol 130: 520-8
18. Eliason MJ, Hansen CB, Hart M et al. (2007) Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Dermatol 143: 1409-12
19. Feige E, Yokoyama S, Levy C et al. (2011) Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF. Proc Natl Acad Sci USA 108:E924-33
20. Garraway LA, Widlund HR, Rubin MA et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-22
21. Ghiorzo P, Pastorino L, Queirolo P et al. (2013) Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. Pigment Cell Melanoma Res 26: 259-62
22. Goldstein AM, Landi MT, Tsang S et al. (2005) Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 14: 2208-12
23. Granter SR, Weilbaecher KN, Quigley C et al. (2002) Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma. Appl Immunohistochem Mol Morphol 10: 47-51
24. Harland M, Goldstein AM, Kukalizch K et al. (2008) A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). Eur J Cancer 44: 1269-74
25. Jaimes N, Braun RP, Thomas L et al. (2012) Clinical and dermoscopic characteristics of amelanotic melanomas that are not of the nodular subtype. J Eur Acad Dermatol Venereol 26: 591-6
26. Law MH, Macgregor S, Hayward NK (2012) Melanoma genetics: recent findings take us beyond well-traveled pathways. J Invest Dermatol 132: 1763-74
27. Liu F, Fu Y, Meyskens FL Jr (2009) MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J Invest Dermatol 129: 422-31
28. McClain SE, Mayo KB, Shada AL et al. (2012) Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences. Int J Dermatol 51: 420-6
29. McClenahan P, Blake T, Douglas N et al. (2012) Quantifying the orientation of acquired melanocytic nevi on the back. Arch Dermatol 148: 857-9
30. Murakami H, Arnheiter H (2005) Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res 18: 265-77
31. Murali R, Goumas C, Kricker A et al. (2012) Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas. Ann Surg Oncol 19: 1024-33
32. Pastorino L, Bonelli L, Ghiorzo P et al. (2008) CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma. Pigment Cell Melanoma Res 21: 700-9
33. Peris K, Fargnoli MC, Pacifico A et al. (2004) CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. J Invest Dermatol 122: 1327-30
34. Puntervoll HE, Yang XR, Vetti HH et al. (2013) Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet 50: 264-70
35. Quint KD, van der Rhee JI, Gruis NA et al. (2012) Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features. Acta Derm Venereol 92: 587-92
36. Salama AK, de Rosa N, Scheri RP et al. (2013) Hazard-rate analysis and patterns of recurrence in early stage melanoma: moving towards a rationally designed surveillance strategy. PloS One 8:e57665
37. Scope A, Burroni M, Agero AL et al. (2006) Predominant dermoscopic patterns observed among nevi. J Cutan Med Surg 10: 170-4
38. Strub T, Giuliano S, Ye T et al. (2011) Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30: 2319-32
39. Thurber AE, Douglas G, Sturm EC et al. (2011) Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene 30: 3036-48
40. Yokoyama S, Woods SL, Boyle GM et al. (2011) A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 480: 99-103
41. Zalaudek I, Guelly C, Pellacani G et al. (2011) The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations. J Invest Dermat 131: 542-5
42. Zalaudek I, Meiklejohn W, Argenziano G et al. (2009) "White" nevi and "red" melanomas: association with the RHC phenotype of the MC1R gene. J Invest Dermat 129: 1305-7